Leaderboard

En | De
Sie sind hier: Gastroenterologie » Leber » Neoplasie 12. November 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Hepatitis
Leberzirrhose
Neoplasie
Portale Hypertonie
Anderes
Magen-Darm
Oesophagus
Pankreas
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 3905  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 78083  
   
Harnessing the Immune System in Hepatocellular Carcinoma Targeting: Mechanistic Insights and Therapeutic Potential of Natural Products and Traditional Chinese Medicine.
Drug Des Devel Ther
Hao L, Li L, Chen Y, Gao J, Xie Y, Li Q, Lu J, Zhang Z.
PMID: 43011505 [PubMed - indexed for MEDLINE]


Decoupled Signal Transduction via a Non-Copper Laccase Mimic for CRISPR-Based Electrochemical Detection of Hepatocellular Carcinoma.
Anal Chem
Li H, Zhou Y, Yan Y, Ye J, Dong X, Chen M, Meng T, Jiao D, Wang D, Zhu L, Yang X.
PMID: 43010442 [PubMed - indexed for MEDLINE]


Double-Lock Superpolymer TDN is Used for the Theranostics of HCC.
Anal Chem
Dou C, Liao C, Liu J, Xie X, Tang M, Cao C.
PMID: 43010402 [PubMed - indexed for MEDLINE]


Ceramide-mediated immunometabolic modulation in hepatocellular carcinoma (HCC): emerging functions of sphingomyelin phosphodiesterase 3 (SMPD3).
Mol Biol Rep
Mohammadi S, Darweesh M, Al-Roshdi M, Rahmati M, Al-Hamadani M, Al-Musharfi M, Al-Harrasi A.
PMID: 43007472 [PubMed - indexed for MEDLINE]


Construction of a UBE2S- and Ferroptosis-Based Prognostic Model for Hepatocellular Carcinoma and Validation of UBE2S-Mediated Ferroptosis.
Hum Mutat
Zhang H, Yao J, Cao J, Guo Z, Jiang W, Li K, Wang X, Mo Z.
PMID: 43005526 [PubMed - indexed for MEDLINE]


HIFU-driven remodeling of fibrotic perivascular myeloid niches in hepatocellular carcinoma: implications for PD-1/PD-L1 blockade.
Front Immunol
Wei Z, Liao Y.
PMID: 43005461 [PubMed - indexed for MEDLINE]


Efficacy and safety of sintilimab plus bevacizumab with or without transarterial chemoembolization for unresectable hepatocellular carcinoma: a propensity score-matched retrospective cohort study.
Front Immunol
Wang Z, Wu B, Wu C, Wu H, Zhao S, Ye S, Li X, Zhan P, Li X, Li Z.
PMID: 43005167 [PubMed - indexed for MEDLINE]


Prognostic Prediction in Living Donor Liver Transplantation Recipients With Complete Pathological Response of Hepatocellular Carcinoma: Single-Center Development and Korea-Nationwide Multi-Center Validation Studies.
Ann Transplant
Kang WH, Hwang S, Ahn CS, Moon DB, Song GW, Jung DH, Park GC, Yoon YI, Lee KW, Kim JM, Joo DJ, You YK, Ryu JH, Han YS, Jeong J.
PMID: 43004659 [PubMed - indexed for MEDLINE]


Subtype conversion and metastatic timing in breast cancer liver metastasis.
World J Surg Oncol
Xue Y, Ou Z, Li A, Huo D, Wang J.
PMID: 43004338 [PubMed - indexed for MEDLINE]


Integrated interpretability machine learning and clinlabomics analysis for the risk prediction of hepatocellular carcinoma.
BMC Cancer
Yang WX, Wang YY, Ye Z, Dang YQ, Wang FF, Gao LN, Zhao DD, He JH, You CG.
PMID: 43004308 [PubMed - indexed for MEDLINE]


Exercise-containing multimodal prehabilitation on functional outcome of patients with hepatobiliary and pancreatic cancer after surgery: a meta-analysis.
BMC Cancer
She Z, Jiang Q, Lu W.
PMID: 43004285 [PubMed - indexed for MEDLINE]


Cancer Immunotherapy for Hepatocellular Carcinoma: Current Drug Strategies, Resistance, Biomarkers, and Future Directions.
Drug Des Devel Ther
Zhong SS, Yu Y, Zhong XH, Xie J, Liu MS.
PMID: 43001154 [PubMed - indexed for MEDLINE]


Combined neutrophil-to-lymphocyte ratio and albumin-bilirubin grade predict survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
BMC Gastroenterol
Hong YM.
PMID: 43000240 [PubMed - indexed for MEDLINE]


Multicenter Retrospective Study of the Impact of Localized Therapy on Prognosis in Patients With Oligometastatic Solid Tumors.
Cancer Med
Deng X, Wu D, Ni L, Li W, Liu Z, Liu J, Liu J.
PMID: 42998017 [PubMed - indexed for MEDLINE]


Preoperative classification of histopathological growth patterns in colorectal liver metastases using prospective 18 F-FDG PET/CT.
Clin Exp Metastasis
Jonsson J, Ling A, Axelsson J, Lundin M, Vermeulen P, Riklund K, Nyström H.
PMID: 42995314 [PubMed - indexed for MEDLINE]


Primary splenic angiosarcoma initially diagnosed as littoral cell angioma: A case report of a diagnostic pitfall.
Medicine (Baltimore)
Yu Y, Zhang H, Zhang G, Xu L.
PMID: 42994881 [PubMed - indexed for MEDLINE]


Synchronous hepatocellular carcinoma and nasopharyngeal carcinoma in a patient with chronic hepatitis B: A case report and literature review.
Medicine (Baltimore)
Zhang S.
PMID: 42994873 [PubMed - indexed for MEDLINE]


Primary-site variation in recorded metastatic patterns and survival associations in extrapulmonary poorly differentiated neuroendocrine carcinoma.
Front Endocrinol (Lausanne)
Liang H, Wu X, Li X, Wu Q, Qiu R, Zheng F.
PMID: 42990865 [PubMed - indexed for MEDLINE]


The Treatment Strategies for Intermediate-Advanced Hepatocellular Carcinoma Based on Albumin-Bilirubin Grade: A Multicenter Retrospective Cohort Study.
Cancer Med
Liang K, Liu J, Pan X, Lin Y, Lin K, Xue H, Li J, Sun H, Wang K, China Liver Cancer Study Group Young Investigators (CLEAP).
PMID: 42989691 [PubMed - indexed for MEDLINE]


The combination of TLSs and the neutrophil-to- monocyte ratio predicts early recurrence in patients with hepatocellular carcinoma.
BMC Cancer
Chen Z, Duan B, Wang X, Zhang G, Wu F, Sun Y, Ouyang Y, Li G.
PMID: 42989148 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 78083    Seite 1 von 3905  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1